Why Big Pharma Stocks Might Be the Next Big Thing

Healthcare leaders gathered in San Francisco for a major industry event. This conference, known for its massive turnout and high-energy atmosphere, brought together CEOs from big and small drug companies. The buzz was around GLP-1 drugs, which have transformed diabetes and obesity treatment and are